Singapore, Korea partner to boost innovation in MedTech

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 04 May, 2015

Singapore: Singapore-Stanford Biodesign (SSB) has inked a three-year pact with Korea's Dongguk University (DU) to train and develop skilled talent in innovative medical technologies. The de...Read more

Korean President rolls out plans to beef up biotech sector

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 28 Apr, 2016

Singapore: With a view to bolster the country's burgeoning biotech sector, the South Korean government recently announced a series of comprehensive plans to ease regulations in its biotech ...Read more

Top 20: SOUTH KOREA - Registers 5% Growth

Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

South Korean publicly listed bioscience companies in 2013 registered combined revenue of $8.3 billion. The leading publicly listed bioscience company in South Korea, Yuhan Corporation, c...Read more

Anteo Diagnostic to enter Korea market

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 20 Oct, 2015

Singapore: Australia based global medical technology company, Anteo Diagnostics, has entered into a non-exclusive distribution agreement with KomaBiotech, a Korean manufacturer and supplier...Read more

Novartis in bribery scandal again,this time in Korea

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 11 Aug, 2016

Singapore:The latest in a string of scandals related to Novartis comes from Korea. As reported by the Korean Herald, six incumbent and former executives of the South Korean unit of Swiss ph...Read more

Seegene develops real-time array to fuel POCT

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

Singapore: Seegene has developed a novel real-time array technology designed specifically to accelerate the development of Point of Care Testing (POCT). The novel real-time array technology...Read more

Asian endoscopy market clocked $264.7 mn in 2012

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

Singapore: Endoscopy devices market in Australia, South Korea, and Southeast Asia, earned revenues of USD264.7 million in 2012 and estimates this to reach USD408.3 million in 2017, accordin...Read more

Korea's LSK Global strengthens ties with Medidata

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2016

Singapore: Korea's leading CRO, LSK Global has expanded its use of Medidata Clinical cloud platform, thus strengthening its global R&D capabilities. The Seoul based organization was est...Read more

Linagliptin efficacy further established in specific patient populations

Korea |  News | By Nandita Singh | 0 Comment | 12 Nov, 2013

Seoul: Boehringer Ingelheim and Eli Lilly & Company have announced new data that reinforces the efficacy and tolerability of linagliptin in patients with Type 2 Diabetes (T2D) and liver...Read more

Boehringer Ingelheim, Hanmi to co-develop lung cancer drug

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2015

Singapore: Boehringer Ingelheim and Korea's Hanmi Pharmaceutical have collaborated for the development and global commercialisation rights, except South Korea, China and Hong Kong, of HM617...Read more

South Korea, EU join hands for bio-nano research

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2015

Singapore: In a bid to boost its biotech and nanotechnology sectors, South Korea has inked a $80 million pact with the European Union (EU) to leverage EU's capabilities in science technolog...Read more

CrystalGenomics partners with Dong-A for Acelex commercialization

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2015

Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercialization of Acelex (polmacoxib) in Korea. Acelex is a tissue-selective, on...Read more

Samsung progresses on RA biosilimar drug ph 3 trial

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2015

Singapore: Korea pharma giant, Samsung Bioepis, has successfully completed Phase 3 clinical study of SB5, an investigational biosimilar of Humira (adalimumab)for treating rheumatoid arthrit...Read more

Vigilant Biosciences enters Korea's oral cancer market

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2015

Singapore: Vigilant Biosciences, developer of early detection and intervention technology for oral cancer, has entered into a five-year exclusive sales and marketing distribution agreement ...Read more

Dong-A Pharma diversifies portfolio to include biosimilars

Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutical industry. Over the years, the company has built alliances with inte...Read more

Samsung to construct a new drug manufacturing plant

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 01 Dec, 2015

Singapore: Samsung BioLogics, biologic drug-manufacturing arm of Samsung Group said that it would invest 850 billion Korean won ($740 million) to construct a new biologic drug manufacturing...Read more

BioElectronics enters Korean pain relief market

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2013

Singapore: BioElectronics, the maker of unique pain relief, inexpensive, patented, consumer medical devices, begun product distribution of its ActiPatch Musculoskeletal Pain Relief, Allay M...Read more

Asia an emerging hotspot in medical tourism

Korea |  Analysis | By Aishwarya Venkatesh  | 0 Comment | 09 Mar, 2015

Singapore: BioSpectrum feels the pulse of Asia's top destinations and major players in medical tourism.  Medical tourism industry is growing worldwide. Frost and Sullivan predicts that t...Read more